Literature DB >> 35133277

Pathway-specific effects of ADSL deficiency on neurodevelopment.

Ilaria Dutto1, Julian Gerhards2,3, Antonio Herrera4, Olga Souckova5, Václava Škopová5, Jordann A Smak6, Alexandra Junza7,8, Oscar Yanes7,8, Cedric Boeckx9,10,11, Martin D Burkhalter2, Marie Zikánová5, Sebastian Pons4, Melanie Philipp2,3, Jens Lüders1, Travis H Stracker1,6.   

Abstract

Adenylosuccinate lyase (ADSL) functions in de novo purine synthesis (DNPS) and the purine nucleotide cycle. ADSL deficiency (ADSLD) causes numerous neurodevelopmental pathologies, including microcephaly and autism spectrum disorder. ADSLD patients have normal serum purine nucleotide levels but exhibit accumulation of dephosphorylated ADSL substrates, S-Ado, and SAICAr, the latter being implicated in neurotoxic effects through unknown mechanisms. We examined the phenotypic effects of ADSL depletion in human cells and their relation to phenotypic outcomes. Using specific interventions to compensate for reduced purine levels or modulate SAICAr accumulation, we found that diminished AMP levels resulted in increased DNA damage signaling and cell cycle delays, while primary ciliogenesis was impaired specifically by loss of ADSL or administration of SAICAr. ADSL-deficient chicken and zebrafish embryos displayed impaired neurogenesis and microcephaly. Neuroprogenitor attrition in zebrafish embryos was rescued by pharmacological inhibition of DNPS, but not increased nucleotide concentration. Zebrafish also displayed phenotypes commonly linked to ciliopathies. Our results suggest that both reduced purine levels and impaired DNPS contribute to neurodevelopmental pathology in ADSLD and that defective ciliogenesis may influence the ADSLD phenotypic spectrum.

Entities:  

Keywords:  ADSL; ADSLD; DNA damage; SAICAR; cell biology; chicken; cilia; developmental biology; human; microcephaly; zebrafish

Mesh:

Substances:

Year:  2022        PMID: 35133277      PMCID: PMC8871376          DOI: 10.7554/eLife.70518

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  62 in total

1.  Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer.

Authors:  Kerstin Holzer; Elisabeth Drucker; Stephanie Roessler; Daniel Dauch; Florian Heinzmann; Nina Waldburger; Eva-Maria Eiteneuer; Esther Herpel; Kai Breuhahn; Lars Zender; Peter Schirmacher; Alessandro Ori; Stephan Singer
Journal:  Am J Pathol       Date:  2016-12-07       Impact factor: 4.307

2.  A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.

Authors:  Mark O'Driscoll; Victor L Ruiz-Perez; C Geoffrey Woods; Penny A Jeggo; Judith A Goodship
Journal:  Nat Genet       Date:  2003-03-17       Impact factor: 38.330

3.  In situ hybridization on whole-mount zebrafish embryos and young larvae.

Authors:  Bernard Thisse; Christine Thisse
Journal:  Methods Mol Biol       Date:  2014

4.  Acentriolar mitosis activates a p53-dependent apoptosis pathway in the mouse embryo.

Authors:  Hisham Bazzi; Kathryn V Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

5.  Grk5l controls heart development by limiting mTOR signaling during symmetry breaking.

Authors:  Martin D Burkhalter; Gregory B Fralish; Richard T Premont; Marc G Caron; Melanie Philipp
Journal:  Cell Rep       Date:  2013-08-22       Impact factor: 9.423

6.  Disruption of mouse Cenpj, a regulator of centriole biogenesis, phenocopies Seckel syndrome.

Authors:  Rebecca E McIntyre; Pavithra Lakshminarasimhan Chavali; Ozama Ismail; Damian M Carragher; Gabriela Sanchez-Andrade; Josep V Forment; Beiyuan Fu; Martin Del Castillo Velasco-Herrera; Andrew Edwards; Louise van der Weyden; Fengtang Yang; Ramiro Ramirez-Solis; Jeanne Estabel; Ferdia A Gallagher; Darren W Logan; Mark J Arends; Stephen H Tsang; Vinit B Mahajan; Cheryl L Scudamore; Jacqueline K White; Stephen P Jackson; Fanni Gergely; David J Adams
Journal:  PLoS Genet       Date:  2012-11-15       Impact factor: 5.917

7.  A versatile viral system for expression and depletion of proteins in mammalian cells.

Authors:  Eric Campeau; Victoria E Ruhl; Francis Rodier; Corey L Smith; Brittany L Rahmberg; Jill O Fuss; Judith Campisi; Paul Yaswen; Priscilla K Cooper; Paul D Kaufman
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

Review 8.  Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer.

Authors:  Michael Paul Kim; Yun Zhang; Guillermina Lozano
Journal:  Front Oncol       Date:  2015-11-11       Impact factor: 6.244

9.  The nonessentiality of essential genes in yeast provides therapeutic insights into a human disease.

Authors:  Piaopiao Chen; Dandan Wang; Han Chen; Zhenzhen Zhou; Xionglei He
Journal:  Genome Res       Date:  2016-07-20       Impact factor: 9.043

10.  RRP7A links primary microcephaly to dysfunction of ribosome biogenesis, resorption of primary cilia, and neurogenesis.

Authors:  Muhammad Farooq; Louise Lindbæk; Nicolai Krogh; Canan Doganli; Cecilie Keller; Maren Mönnich; André Brás Gonçalves; Srinivasan Sakthivel; Yuan Mang; Ambrin Fatima; Vivi Søgaard Andersen; Muhammad S Hussain; Hans Eiberg; Lars Hansen; Klaus Wilbrandt Kjaer; Jay Gopalakrishnan; Lotte Bang Pedersen; Kjeld Møllgård; Henrik Nielsen; Shahid M Baig; Niels Tommerup; Søren Tvorup Christensen; Lars Allan Larsen
Journal:  Nat Commun       Date:  2020-11-16       Impact factor: 14.919

View more
  1 in total

1.  Pathway-specific effects of ADSL deficiency on neurodevelopment.

Authors:  Ilaria Dutto; Julian Gerhards; Antonio Herrera; Olga Souckova; Václava Škopová; Jordann A Smak; Alexandra Junza; Oscar Yanes; Cedric Boeckx; Martin D Burkhalter; Marie Zikánová; Sebastian Pons; Melanie Philipp; Jens Lüders; Travis H Stracker
Journal:  Elife       Date:  2022-02-08       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.